HARVARD MANAGEMENT CO INC - XILIO THERAPEUTICS INC ownership

XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 42 filers reported holding XILIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
HARVARD MANAGEMENT CO INC ownership history of XILIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$878
-19.4%
416,0590.0%0.10%
-7.5%
Q2 2023$1,090
-99.9%
416,0590.0%0.11%
-23.0%
Q1 2023$1,323,068
+18.2%
416,0590.0%0.14%0.0%
Q4 2022$1,119,199
-7.6%
416,0590.0%0.14%
-7.9%
Q3 2022$1,211,000
-0.3%
416,0590.0%0.15%
+7.1%
Q2 2022$1,215,000
-58.7%
416,0590.0%0.14%
-52.5%
Q1 2022$2,942,000
-55.8%
416,0590.0%0.30%
-52.5%
Q4 2021$6,657,000416,0590.62%
Other shareholders
XILIO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,441,444$3,041,4477.52%
Trustees of Columbia University in the City of New York 249,635$526,7300.97%
Atlas Venture Life Science Advisors, LLC 2,759,344$5,822,2160.90%
Octagon Capital Advisors LP 2,318,500$4,892,0350.75%
Bain Capital Life Sciences Investors, LLC 2,805,413$5,919,4210.66%
HARVARD MANAGEMENT CO INC 416,059$8780.10%
Rock Springs Capital Management LP 1,440,759$3,040,0010.08%
Soleus Capital Management, L.P. 226,941$478,8460.04%
Artal Group S.A. 450,000$9500.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,481$233,1150.01%
View complete list of XILIO THERAPEUTICS INC shareholders